Investors & Media
VYNE Therapeutics™ is a biopharmaceutical company.
Committed to addressing unmet needs and providing new options for patients with immuno-inflammatory conditions.
NASDAQ-GS: VYNE
2.50
Apr. 26, 2024 16:00:00- Change 0.03 (1.2146%)
- Volume 15,849
- Today's Open 2.53
- Previous Close 2.47
- Today's High 2.53
- Today's Low 2.42
- 52 Week High 8.73
- 52 Week Low 1.67